XML 67 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 29, 2014
Mar. 30, 2013
Mar. 31, 2012
Cash flows from operating activities      
Net income $ 661,485 $ 397,602 $ 147,364
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 79,654 54,291 37,554
Impairment and write-off of property and equipment 1,332 725 3,292
Loss on disposal of fixed assets 3,758 229  
Unrealized foreign exchange loss (gain) 131 1,363 (2,629)
Income earned on joint venture (354)    
Amortization of deferred financing costs 746 703 498
Amortization of deferred rent 6,333 3,245 4,214
Deferred income taxes (29,905) 3,222 (7,729)
Equity compensation expense 29,078 20,932 27,020
Tax benefits on exercise of share options (54,693) (144,508) (32,281)
Non-cash charges for services provided by former parent   258 1,442
Change in assets and liabilities:      
Receivables, net (105,648) (80,581) (48,399)
Inventories (158,243) (81,108) (71,151)
Prepaid expenses and other current assets (5,222) (3,866) (12,647)
Other assets (4,274) 6 (2,284)
Accounts payable 49,034 16,299 14,888
Accrued expenses and other current liabilities 133,208 152,630 46,419
Other long-term liabilities 25,359 14,894 9,719
Net cash provided by operating activities 631,779 356,336 115,290
Cash flows from investing activities      
Capital expenditures (184,738) (121,321) (88,187)
Equity method investments (1,960) (3,232)  
Loans receivable-joint venture   (6,000)  
Purchase of intangible assets (28,822) (8,546)  
Net cash used in investing activities (215,520) (139,099) (88,187)
Cash flows from financing activities      
Repayments of borrowings under revolving credit agreement (21,120) (38,954) (100,855)
Borrowings under revolving credit agreement 21,120 16,280 110,764
Proceeds from private placement     9,550
Exercise of employee share options 18,988 30,435 9,672
Purchase of Treasury Shares (2,447)    
Tax benefits on exercise of share options 54,693 144,508 32,281
Payment of deferred financing costs (176) (1,708) (2,773)
Net cash provided by financing activities 71,058 150,561 58,639
Effect of exchange rate changes on cash and cash equivalents (4,683) (1,641) (453)
Net increase in cash and cash equivalents 482,634 366,157 85,289
Beginning of period 472,511 106,354 21,065
End of period 955,145 472,511 106,354
Supplemental disclosures of cash flow information      
Cash paid for interest 699 484 1,266
Cash paid for income taxes 280,667 70,500 84,389
Supplemental disclosure of noncash investing and financing activities      
Accrued capital expenditures $ 16,324 $ 12,289 $ 6,869